NCT05040191 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Choi KS, He XJ, Chiang VC, Deng Z, Qin J
A Heuristic Force Model for Haptic Simulation of Nasogastric Tube Insertion Using Fuzzy Logic. IEEE Trans Haptics. 2016 Jul-Sep;9(3):295-310. doi: 10.1109/TOH.2016.2550044. Epub 2016 Apr 6.
SENDIR, M
, & KIZIL, H. (2019). An innovative approach in teaching nasogastric tube application: NAZO-AR. Journal of Duzce University Institute of Health Sciences, 9(2), 86-90.

The Effect of Haptic Interactive Virtual Reality and Computer-Based Simulation Technologies on Students' Achievement and Anxiety Levels in Nasogastric Tube Practice Teaching

Details for clinical trial NCT05040191

Clinical trial NCT05040191 - References